Oxervate (cenegermin-bkbj) prior authorization
Defines UnitedHealthcare prior authorization requirements for Oxervate (cenegermin-bkbj) for treatment of neurotrophic keratitis, affecting providers prescribing this medication to UnitedHealthcare members.
No material clinical or coverage changes in this revision.
Coverage Criteria
Initial authorization
Covered when ALL of the following are met:
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.